Replies to post #140059 on Anavex Life Sciences Corp (AVXL)

[TomP1]

Something about a needle and a haystack...

I guess it’s good that they do it before the trial start rather then afterwards like most other companies.

[Investor2014]

The Company is planning to use a similar process and trial design for the Parkinson’s disease Phase 2 study, for which the clinical site validation has been completed.

Could this indicate that the PD trial may kick off in Sweden earlier than the AD trial?

[LakeshoreLeo1953]

I read it entirely differently.

The "present quarter" and should/may/plan equivocations
will NOT be viewed well.

RETT is the easiest trial to populate and even there
a re submission will occur.

For an audience COUNTING on positive forward motion
this may feed the loyalists, but no excitement for the
curious let alone the naysayers.